Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Outlook Therapeutics Inc (NQ: OTLK )

7.550 -0.180 (-2.33%)
Streaming Delayed Price Updated: 3:52 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Outlook Therapeutics Inc

< Previous 1 2 3 4 Next >
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
Via Benzinga
What's Next For Stocks After S&P 500 Wraps Roughest Year Since 2008?
The SPDR S&P 500 ETF Trust (NYSE: SPY) 500 declined for the fourth consecutive week as the stock market completed its worst year in more than a decade. 
Via Benzinga
Earnings Scheduled For December 27, 2022
Companies Reporting Before The Bell • Outlook Therapeutics (NASDAQ:OTLK) is expected to report earnings for its fourth quarter.   This article was generated by Benzinga's automated content engine and... 
Via Benzinga
Earnings Outlook For Outlook Therapeutics
Via Benzinga
Outlook Therapeutics Shares Pop After Filing US Application For Its Lead Eye Disease Candidate
Via Benzinga
Can The Economy Weather Inflation, A Winter Storm, Elon Musk?
The S&P 500 traded lower for the third consecutive week on concerns inflation may be more stubborn than anticipated. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
Upgrades 
Via Benzinga
TRACON Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
US gold futures traded slightly higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million. 
Via Benzinga
A Major October Catalyst Could Make This Eye Stock A Ten Bagger, Analyst Says
Chardan initiated coverage on Outlook Therapeutics Inc (NASDAQ: OTLK) with a Buy rati 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022
Upgrades See all analyst ratings upgrades. 
Via Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
44 Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
82 Biggest Movers From Yesterday
Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
62 Biggest Movers From Yesterday
Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, investors! Busy traders are already at work this morning as we go over the biggest pre-market stock movers for Wednesday. 
Via InvestorPlace
18 Stocks Moving in Wednesday's Pre-Market Session
Gainers Endo International plc (NASDAQ: ENDP) rose 46.1% to $0.7710 in pre-market trading after gaining over 12% on Tuesday. 
Via Benzinga
77 Biggest Movers From Yesterday
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 36 companies achieved new lows for the year. 
Via Benzinga
4 Penny Stocks Insiders Are Buying
US crude oil futures traded higher by around 4% on Friday. Investors, meanwhile, focused on some notable insider trades When insiders pur... 
Via Benzinga
4 Penny Stocks Insiders Are Buying
China’s official NBS manufacturing PMI rose to 50.2 in February from January's figure of 50.1. Investors, meanwhile, focused on some nota... 
Via Benzinga
Outlook Therapeutics And 4 Other Penny Stocks Bought By Insiders
Asian markets tumbled on Thursday after news emerged that Russia’s President Vladimir Putin has announced a “special military operation... 
Via Benzinga
Outlook Therapeutics: Q1 Earnings Insights
  Outlook Therapeutics (NASDAQ:OTLK) reported its Q1 earnings results on Monday, February 14, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Sensus Healthcare (NASDAQ:SRTS) shares moved upwards by 18.6% to $8.1 during Wednesday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
Recap: Outlook Therapeutics Q4 Earnings
Outlook Therapeutics (NASDAQ:OTLK) reported its Q4 earnings results on Wednesday, December 22, 2021 at 08:00 AM. Here's what investors need to know about the... 
Via Benzinga
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Angion Biomedica's ANG-3777 Does Not Meet Primary Endpoint In Mid-Stage... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.